SAN RAFAEL, Calif., Nov. 6, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at three upcoming investor conferences. BioMarin ...

Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Global Markets to 2029" looks at the growing demand for inactive ingredients in medications. The market for Excipients, which enhance drug stability ...

Q3 2024 Earnings Call Transcript November 7, 2024 BlackLine, Inc. beats earnings expectations. Reported EPS is $0.6, ...

Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies ...

Zealand Pharma A/S ( (ZLDPF) ) has released its Q3 earnings. Here is a breakdown of the information Zealand Pharma A/S presented to its ...

Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise. Lexicon Pharmaceuticals NewsMORE Related ...

Iran seems to have weaponized the pharmaceutical fentanyl. It may have given these chemical weapons to Hamas and Hezbollah to ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

South Korea’s reputable yet increasingly taxed healthcare industry depends on a robust pharmaceutical sector. As domestic and international demand has increased, the country has further proven ...

Explore how dynamic vapor sorption (DVS) technology is revolutionizing pharmaceutical development by improving material ...